Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AC-261066 is an orally available and isoform-selective agonist of RARβ2 with a pEC50 of 8.0.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 10,000 | |||
5 mg | 在庫あり | ¥ 22,500 | |||
10 mg | 在庫あり | ¥ 41,000 | |||
25 mg | 在庫あり | ¥ 91,500 | |||
50 mg | 在庫あり | ¥ 135,500 | |||
100 mg | 在庫あり | ¥ 193,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 27,000 |
説明 | AC-261066 is an orally available and isoform-selective agonist of RARβ2 with a pEC50 of 8.0. |
ターゲット&IC50 | RARβ2:8.0 (pEC50) |
別名 | AC 261066 |
分子量 | 353.41 |
分子式 | C17H20FNO4S |
CAS No. | 870773-76-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/mL (113.2 mM), Sonication and heating to 80℃ are recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AC-261066 870773-76-5 Metabolism Retinoid Receptor AC 261066 AC261066 Inhibitor inhibitor inhibit